Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2001

• Venue

  AIDS (London)

• Publication date

  2001-01-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002030-200101050-00006PMID 11192865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

  2000cited by this paper
• Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.

  2000cited by this paper
• Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

  2000cited by this paper
• Clearance of cytomegalovirus viremia after initiation of highly active antiretroviral therapy.

  2000cited by this paper
• Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity.

  2000cited by this paper
• Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.

  1999cited by this paper
• Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.

  1999cited by this paper
• Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.

  1999cited by this paper
• Bronchopulmonary dysplasia--no simple solution.

  1999cited by this paper
• Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

  1999cited by this paper
• Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.

  1999cited by this paper
• Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study

  1999cited by this paper
• Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.

  1999cited by this paper
• Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.

  1999cited by this paper
• Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

  1999cited by this paper
• Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

  1998cited by this paper
• Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients

  1998cited by this paper
• Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.

  1998cited by this paper
• Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

  1998cited by this paper
• Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

  1998cited by this paper
• Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.

  1998cited by this paper
• Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.

  1998cited by this paper
• Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment

  1998cited by this paper
• Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

  1997cited by this paper
• Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.

  1997cited by this paper
• High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up

  1996cited by this paper
• Significance of cytomegalovirus (CMV)‐pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus‐infected patients

  1996cited by this paper
• Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.

  1996cited by this paper
• Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.

  1995cited by this paper
• Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.

  1993cited by this paper
• A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group.

  1993cited by this paper
• A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDS

  1993cited by this paper
• Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.

  1992cited by this paper
• Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

  1991cited by this paper
• A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.

  1991cited by this paper
• Ocular manifestations of acquired immune deficiency syndrome.

  1989cited by this paper
• Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

  1988cited by this paper
• The New England Jour nal of Medicine DISCONTINUATION OF PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN HIV-1–INFECTED ADULTS TREATED WITH COMBINATION ANTIRETROVIRAL THERAPY

  year unknowncited by this paper

• Cytomegalovirus (CMV) is a double-stranded DNA virus in the herpesvirus family that can cause disseminated or localized end-organ disease in people with HIV with advanced immunosuppres-

  2021cites this paper
• Cytomegalovirus

  2021cites this paper
• Cytomegalovirus Disease

  2021cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el año 2008

  2020cites this paper
• Cytomegalovirus

  2019cites this paper
• Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment

  2017cites this paper
• 94 – Opportunistic Infections: Management and Prevention

  2017cites this paper
• Cytomegalovirus

  2016cites this paper
• Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting.

  2015cites this paper
• Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy

  2014cites this paper
• An overview of current and future treatment options for patients with cytomegalovirus retinitis

  2014cites this paper
• Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediat

  2013cites this paper
• Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

  2013cites this paper
• Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency

  2013cites this paper
• Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/OAG) (AWMF 055/066)

  2013cites this paper
• Sexuality and risk behavior among men who have sex with men in León, Nicaragua: a mixed methods approach.

  2012cites this paper
• Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand

  2012cites this paper
• Combination Therapy of AIDS

  2012cites this paper
• Economic Evaluation for Treatments of Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand (การประเมินความคุ้มค่าทางเศรษฐศาสตร์ของวิธีการรักษาทางติดเชื้อ CMVR ในจอประสาทตาของผู้ป่วยติดเชื้อเอชไอวี/เอดส์ ในประเทศไทย)

  2011cites this paper
• Lack of TNF-alpha promotes caspase-3-independent apoptosis during murine cytomegalovirus retinitis.

  2011cites this paper
• PROPORCION DE LA INFECCION POR CITOMEGALOVIRUS (CMV) EN PACIENTES CON TRATAMIENTO ANTIRRETROVIRAL DE GRAN ACTIVIDAD (TARGA)

  2010cites this paper
• HIV: primary and secondary prophylaxis for opportunistic infections.

  2010cites this paper
• Immune-based therapies for cytomegalovirus infection.

  2010cites this paper
• Prevention of opportunistic infections

  2010cites this paper
• 15 – Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome: Diagnosis and Management

  2010cites this paper
• CHAPTER 53 – Infections of the eye

  2010cites this paper
• Prevention of opportunistic infections in HIV-infected adolescent and adult patients . Guidelines from GESIDA / National AIDS Plan , 2008

  2009cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and

  2009cites this paper
• Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el año 2008 Recomendaciones del Grupo de Estudio del Sida (GESIDA)/ Plan Nacional sobre el Sida

  2008cites this paper
• [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan].

  2008cites this paper
• Vaginal microbicides: moving ahead after an unexpected setback

  2007cites this paper
• Antiretroviral treatment of HIV infection: Swedish recommendations 2007

  2007cites this paper
• Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa

  2007cites this paper
• Tumor Necrosis Factor-α–Induced Apoptosis in Murine Cytomegalovirus Retinitis

  2007cites this paper
• Multiorganinfektionen — komplexe klinisch infektiologische Krankheiten

  2007cites this paper
• Cytomegalovirus retinitis

  2007cites this paper
• Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.

  2007cites this paper
• Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis.

  2007cites this paper
• Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

  2006cites this paper
• Long-Term Follow-up of a Cohort of HIV-Infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis

  2006cites this paper
• A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102

  2006cites this paper
• Leishmania/HIV co-infections in the second decade.

  2006cites this paper
• Immunological recovery and antiretroviral therapy in HIV-1 infection.

  2006cites this paper
• Chapter 92 – Retinal Disease in HIV-infected Patients

  2006cites this paper
• The Effect of Venue Sampling on Estimates of HIV Prevalence and Sexual Risk Behaviors in Men Who Have Sex With Men

  2006cites this paper
• HIV-ASSOCIATED RETINOPATHY IN THE HAART ERA

  2005cites this paper
• Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

  2005cites this paper
• Gastrointestinal tract cytomegalovirus disease in southwestern Taiwan: a clinical study of 1950 endoscopic biopsies.

  2005cites this paper
• Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective

  2005cites this paper
• Multiorganinfektionen — komplexe klinisch-infektiologische Krankheiten

  2005cites this paper
• Chapter 13 – Care of the Adult Patient with HIV Infection

  2004cites this paper
• Effects of highly active antiretroviral therapy among HIV-infected patients

  2004cites this paper
• Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

  2004cites this paper
• Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

  2004cites this paper
• Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH. Recomendaciones de GESIDA/Plan Nacional sobre el Sida

  2004cites this paper
• HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment

  2004cites this paper
• Immune reconstitution in HIV infection

  2004cites this paper
• Illness of immune reconstitution: Recognition and management

  2004cites this paper
• Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy

  2004cites this paper
• Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.

  2004cites this paper
• Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis

  2004cites this paper
• Drugs and the retina

  2004cites this paper
• Posterior segment manifestations of HIV/AIDS.

  2004cites this paper
• Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.

  2004influential citation
• Drugs and the retina.

  2004cites this paper
• Evaluating therapeutic vaccines in patients infected with HIV

  2004cites this paper
• Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.

  2004influential citation
• A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy

  2004cites this paper
• Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.

  2004cites this paper
• Discontinuation of prophylaxis for HIV-associated opportunistic infections in the era of highly active antiretroviral therapy.

  2004cites this paper
• Frequency, risk factors and features of hyperlactatemia in a large number of patients undergoing antiretroviral therapy

  2003cites this paper
• The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.

  2003cites this paper
• Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV‐infected patients and their epidemiologic characteristics

  2003cites this paper
• High‐frequency interferon‐γ‐secreting splenocytes specific for murine cytomegalovirus immediate‐early‐1 (IE‐1) peptide 168YPHFMPTNL176 are insufficient to provide complete protection from viral challenge

  2003cites this paper
• Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.

  2003cites this paper
• Cytomegalovirus disease in the highly active antiretroviral therapy era

  2003cites this paper
• Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.

  2003cites this paper
• Changing Patterns of Prophylaxis and Treatment of Bacterial and Viral Intestinal Infections

  2003cites this paper
• Restoration of Human Immunodeficiency Virus‐1‐Specific Responses in Patients Changing from Protease to Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Antiretroviral Therapy

  2003cites this paper
• Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.

  2003cites this paper
• The immune reconstitution inflammatory syndrome.

  2003cites this paper
• Therapeutic vaccines against HIV need international partnerships

  2003cites this paper
• Prophylaxis of Herpesvirus Infections in Immunocompetent and Immunocompromised Older Patients

  2002cites this paper
• Infecciones víricas relacionadas con la infección por VIH

  2002cites this paper
• Manifestations cliniques de l'infection par le virus de l'immunodéficience humaine

  2002cites this paper
• Immune Reconstitution Inflammatory Syndrome: Emergence of a Unique Syndrome During Highly Active Antiretroviral Therapy

  2002cites this paper
• Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*

  2002cites this paper
• Guidelines for laboratory monitoring of treatment of persistent virus infections.

  2002cites this paper
• Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

  2002cites this paper
• Ocular manifestations of HIV/AIDS.

  2002cites this paper
• Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.

  2002cites this paper
• HIV-1 therapeutic vaccines.

  2002cites this paper
• Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.

  2002cites this paper
• Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy.

  2002cites this paper
• [Legionellosis in HIV-1 infected patients. 4 case reports].

  2002cites this paper
• Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

  2002cites this paper
• Management of opportunistic infection prophylaxis in the highly active antiretroviral therapy era

  2002cites this paper
• Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.

  2001cites this paper
• Sustained Cytomegalovirus-Specific CD4+ T Cell Response Associated with Prevention of Recurrence of Cytomegalovirus Retinitis without Secondary Prophylaxis after Highly Active Antiretroviral Therapy in Patients with AIDS

  2001cites this paper